Lv1
20 积分 2023-02-25 加入
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
15天前
已完结
First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial
3个月前
已完结
Hepatic Pseudoprogression after Treatment with Nectin-4–Targeted Antibody–Drug Conjugate
4个月前
已完结
[Consensus on clinical diagnosis and treatment of breast cancer with low expression and ultralow expression of HER-2 (2025 edition)]
4个月前
已完结
Cryoablation Activates the cGAS–STING‐CXCL10 Axis in Macrophages to Enhance Anti‐Tumor Immunity in NSCLC
5个月前
已完结
PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence
9个月前
已完结
[Chinese experts consensus on the diagnosis and management of checkpoint inhibitor pneumonitis(2025)]
11个月前
已完结
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
11个月前
已完结
Twenty-years experience withde novometastatic breast cancer
11个月前
已完结
Trends in Metastatic Breast and Prostate Cancer — Lessons in Cancer Dynamics
11个月前
已完结
皖公网安备34019202002308
